Navigation Links
Xlumena, Inc. Closes $7M Series B Venture Financing Round
Date:4/28/2011

MOUNTAIN VIEW, Calif., April 28, 2011 /PRNewswire/ -- Xlumena, a privately held provider of innovative technology for the interventional endoscopist and endoscopic surgeon, today announced it has successfully closed its Series B financing.

The current round of financing was led by new investor, Aperture Venture Partners, LLC and joined by Western Technology Investment. In conjunction with the financing, Eric Sillman of Aperture Venture Partners and Avi Kometz, MD of Ascent Biomedical Ventures will join Xlumena's Board of Directors.  "Xlumena has tremendous potential to deliver innovative devices to the emerging field of interventional and therapeutic endoscopy.  We are excited to lead the Series B financing and to begin collaborating with Xlumena's team to expand the impact of their novel technologies," stated Eric Sillman, General Partner of Aperture Venture Partners.

Also participating in the current round of financing were existing institutional investors Prism Ventures, Charter Life Sciences and Ascent Biomedical Ventures. "We are pleased to close our Series B with Aperture as the lead. This financing will support our market introductions in the US and Europe.  We are very fortunate to have top-tier investors supporting Xlumena's growth," stated Michael Allen, President and CEO of Xlumena.

About Xlumena, Inc.

Xlumena, Inc. is a privately-held interventional endoscopy-focused medical device company based in Mountain View, California.  The Company has a number of advanced therapeutic devices in various stages of development, including the NAVIX™ Access Device (FDA-cleared) and the AXIOS™ Stent and Delivery System (CE marked).  Formed in 2008 by Kenneth Binmoeller, MD (California Pacific Medical Center) and Michael Allen, Xlumena has raised $19M from venture capital sources to date.

For more information: http://xlumena.com  


'/>"/>
SOURCE Xlumena, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CoDa Therapeutics Closes $19 Million Series B Financing Round
2. Benvenue Medical Closes $35.5 Million Series C Financing
3. PixelOptics Closes $45 Million Financing
4. AnaBios Corporation Closes Series A Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. OncoSec Medical Closes $1.1M Financing
7. Patient Safety Technologies, Inc. Closes $7.1 Million Common Stock Offering
8. BridgePoint Medical Closes $9.1 Million Series C Financing
9. Palatin Technologies, Inc. Closes $23 Million Public Offering
10. Sonoma Orthopedic Products® Closes $22 Million Series D Financing
11. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) is pleased ... Pharm D., to Vice President of Education and Quality. ... will continue to lead and oversee Diplomat University, an ... and training to Diplomat employees and external professionals on ... also houses the quality assurance department, which focuses on ...
(Date:4/26/2016)... 2016 US demand for infection prevention ... percent annually to $27.6 billion in 2020.  Increasing ... decrease rates of healthcare-associated infections (HAIs) will boost ... services.  Although declining, the overall rate of certain ... set by the CDC.  Recent statistics indicate that ...
(Date:4/26/2016)... DUBLIN , April 26, 2016 ... "Financial Assessment and Credit Risk Analysis of the Biological ... This comprehensive report analyzes the financial assessment ... China . The report provides readers ... key topics all market participants should be aware of. ...
Breaking Medicine Technology:
(Date:4/28/2016)... , ... April 28, 2016 , ... La Sirena Foods ... one in Central America and is looking to grow their market share in the ... an exceptional brand as La Sirena Foods and indirectly with Otis ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... today the open availability of a new CDISC standard, Clinical Trial Registry ... clinical trials. This innovative standard will make it possible to build applications ...
(Date:4/28/2016)... West Palm Beach, FL (PRWEB) , ... April 28, 2016 , ... ... time for the spring season. Smart pots are frequently used by professional organic farmers ... time for growers to order their supply of fabric pots. Our goal is to ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... enterprise Data Center Infrastructure Management solutions, announces today the availability of its ... in the area of capacity management and optimization, providing new analytical capabilities ...
(Date:4/28/2016)... ... April 28, 2016 , ... USA Medical Card reminds us that May is National Stroke Awareness ... the fourth leading cause of death in the United States; someone has one every 40 ... them in individuals under 65 years old. A stroke is when blood flow to ...
Breaking Medicine News(10 mins):